Fosun Pharma: Net profit in the first half of 2025 is expected to be around 390 million yuan, an increase of about 1% year-on-year.

Fosun Pharma announced its interim financial results on the Hong Kong Stock Exchange, with a revenue of approximately 2.82 billion yuan in the first half of the year, a year-on-year increase of 2.7%; and a net profit of about 390 million yuan, a year-on-year increase of about 1%.